רפמיון 1 מ"ג

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

SIROLIMUS 1.00 MG

제공처:

NEOPHARM LTD

ATC 코드:

L04AA10

약제 형태:

COATED TABLETS

관리 경로:

PER OS

Manufactured by:

PFIZER IRELAND PHARMACEUTICALS

치료 그룹:

SIROLIMUS

치료 징후:

Rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. It is recommended that Rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. Rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.

승인 날짜:

2009-10-01